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ABSTRACT 
The central neurochemical effects of chronic low doses (0.5 or 5 
mg/kg, s.c., every 12 h for 2 wk) of d-amphetamine (AMPH) were studied 
in rats of varying ages. Tyrosine hydroxylase (TH) and tryptophan 
hydroxylase (TPH) activities in neostriata of male offspring of dams 
exposed to 5 mg/kg AMPH during gestaton showed significant depressions 
at 3 weeks of age, while corresponding neurotransmitters were at con-
trol levels. In contrast, the striatal enzyme activities in the dams 
were normal, but significant depressions were observed in the levels 
of striatal 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid 
(5-HIAA), dopamine (DA) , 3,4-dihydroxyphenylacetic acid (DOPAC), and 
homovanillic acid (HVA). All parameters returned to normal by 7 
weeks. Neurochemical change s were minimal in juvenile and adul t 
males subjected to the same AMPH do sing regimen. The hypothalamic 
concentrations of 5-HT, 5-HIAA, and DA in adult males were reduced at 
16 h, but these parameters were unaffected in the juveniles. Recovery 
in the adults was complete by 3 wks post dosing. No effects were seen 
with the lower dose of AMPH (0.5 mg/kg) in any age group. The chronic 
doses of AMPH used in this study are not as toxic to the central sero-
tonergic or dopaminergic systems of the rat as higher doses that have 
previously been studied in acute and subacute dosing regimens. Under 
these conditions, the age of the animal at the time of drug exposure 
did not significantly alter the severity of the toxicity that was ob-
served. Further, our data suggest that the neurotoxicity of AMPH is 
highly dependent on dose and duration of exposure. 
v 
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INTRODUCTION 
The neurochemical changes induced by high-dose, short-term 
exposure ~o amphetamines have been examined in great 1 9-detail ' 
12,14,15,17,18,33,38 Multiple injections of methamphetamine (METH) 
(10-15 mg/kg/ do se) over 18-36 hours cause severe depres sions of the 
serotonergic and dopaminergic systems in several discrete brain 
. of h 10,14,15,33 reglons t e rat . This is not a generalized neurotoxic 
effect, as cholinergic and GABA-ergic systems in the same areas are 
not similarly affectedl5 . Furthermore, striatal tyrosine hyroxylase 
(TH) 1,9 and tryptophan hydroxylase (TPH) 1 activities and 5-hydroxy-
tryptamine (5-HT) levels1 remain depressed as long as 110 days after 
dosing. Similarly, a single dose of amphetamine (AMPH) to iprindole-
treated rats causes a decrease in striatal dopamine (DA) that persists 
at least 7 daysl1,12,38. 
Amphetamine-induced neurotoxicity has also been approached 
from a developmental standpoint. Wagner et- al. 40 found that JO-day 
old rats exposed to very high doses of AMPH (25 mg/kg) twice daily for 
30 days had depressed caudate DA levels at 2 weeks post-dosing. How-
ever, the magnitude of the change was significantly less than that 
previously reported in adul t animals39 • Lal and Feldmuller20 calcu-
lated the whole brain half-life of AMPH in 12-day old rats to be 150 
minutes, compared to 66 minutes in adul ts. In spite of this slower 
clearance, peak AMPH levels after a single injection of the drug were 
2 
found to be lower in the immature than in the adult anima1s20 • 
High-dose acute or subacute studies are important in de1ineat-
ing the mechanisms of drug-induced toxicity and for providing animal 
models for the study of drug abuse. We were interested, however, in 
the neurochemical consequence~ of more clinically relevant AMPH 
exposure. AMPH is used therapeutically in low doses for the treatment 
of such diverse disorders as obesity, narcolepsy, and attention 
deficit disorder (ADD; i. e. minimal brain dysfunction, hyperkine-
. )41 S1S • The latter condition, ADD, is most frequently recognized and 
trea ted in young children. The current research was designed to 
examine the neurochemical effects of chronic, low doses of AMPH and to 
determine whether any of the drug-induced changes are dependent on the 
age of the animal at the time of exposure. 
MATERIALS AND METHODS 
Adult male (180-200g), juvenile male (I-week old), and timed-
pregnant female (day 2 of gestation) Sprague-Dawley rats were obtained 
from Simonsen 'Labs. Animals were housed in groups except for the 
pregnant females, which were housed separately. All rats were main-
tained in temperature-controlled rooms (24 0 C) and were allowed accesS 
to food and water ad libitum. 
Experimental animals received d-amphetamine (0.5 or 5 mg/kg, 
s.c.) every 12 hours for two weeks; controls received equivalent vol-
umes of· the saline vehicle. Twice daily do sing with· 0.5 mg/kg AMPH 
was selected for study as an approximation of the regimen used clini-
cally in children for the treatment of ADD. The higher dose,S mg/kg, 
was included for purposes of direct comparison with the effects of the 
lower do sea Without assuming direct correIa tions between human use 
and our animal model, 5 mg/kg AMPH twice daily represents a dose level 
somewhat higher than is routinely used clinically in adults (e.g. nar-
colepsy, obesity). Higher doses could not be employed in this study 
due to an exceptionally high mortality rate in the pregnant f em.ale s. 
Under the conditions described here mortality was less than 5 percent. 
Figure 1 is a schematic representation of the dosing regimen 
and sacrifice schedule used in this study. Juvenile males were dosed 
beginning on postnatal day 14. Females were dosed from day 7 of ges-
tation through day 20; the last dose was given 12-24 hours before par-
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Experimental Design. 
Amphetamine was administered subcutaneously every 12 hours for 2 weeks 
(shown by l2j.t :41l). Offspring of the treated darns were weaned on 
postnatal day 21 ('6.). Individual animals from each group were sacri-
ficed at time points designated by )\. Sacrifice at Time 0 in the 
juvenile and adult males represents a time of 16 hours post-dosing. 
.+:--
5 
turition. Mal e of f spring of these dams, which were included in the 
neurochemical analyses, were exposed to AMPH in utero only. Indi-
vidual animals from each group were sacrificed at the times shown in 
Figure 1. To allow ample differentiation of the brain for dissection, 
the earlie st time of sacrifice of the offspring was three weeks. 
Females were required for nursing of the young until weaning at 21 
days. 
Rats were sacrificed between 09.00 and 12.00 hours to minimize 
the effects of diurnal and/or circadian rhythms on neurochemical ac-
tivity. Rats were decapitated and the whole brain placed immediately 
on ice. Neostriatum, cerebral cortex, and hypothalamus were dissected 
out and frozen separately (-70 0 C) in paraf ilm until analyses were 
performed. These brain regions were selected for study since the 
cortex and striatum have been reported to be particularly sensi-
tive1 ,14,23,33 and the hypothalamus more resistant l ,33 to the toxicity 
of the amphetamines. In addi tion, the developmental state of the 
hypothalamic hormonal influence was of interest for the comparison of 
the responses observed in the immature versus adult animals. 
In neostriatum and cortex, enzyme activities were measured as 
f 11 TPH .. b d . f· d 14CO . h d 16 ,37 o ows: act~v~ty y a mo ~ ~e 2-trapp~ng met 0 as 
described previously by Hotch~iss et al. 15 , TH activity by the method 
25 
of Naga tsu et a 1. In hypothalamus, as well as neostriatum and 
cortex, selected monoamines and metabolites were also measured. High 
performance liquid chromatography with electrochemical detection 
(HPLC-EC) was utilized to quantitate simultaneously 5-HT, 5-HIAA, DA, 
3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA), 
6 
27 
using a modification of the method described by Neilsen and Moore . 
The HPLC conditions were as follows: Waters microbondapak C-18 
reverse-phase analytical column (10 micron) with a mobile phase con-
sisting of 0.1 M citric acid (anhydrous), 0.1 M potassium phosphate 
dibasic, 12.5% methanol, 0.004% sodium heptane sulfonic acid, and 1 mM 
EDTA, adjusted to a final pH of 3.5. Use of the present counter-ion 
in this procedure resulted in a different separation (Figure 2) than 
was previously described27 using sodium octane sulfonic acid. Elec-
trochemical detection (Bioanalytical Systems) was at a potential of 
+0.73V. 
Brain regions were homogenized in the mobile phase buffer and 
centrifuged at 41,300 x g for 20 minutes. The supernatant was fil-
tered across densely packed glass wool and a 50 1-11 aliquot inj ected 
directly onto the chromatography column. Quantitation of samples was 
achieved by comparison of peak heights to those of standard solutions 
injected daily. 
The Student's t-test6 was used to compare the appropriate con-
trol and treated groups, and in all cases a p value of < 0.05 was used 
to assign statistical significance. 
Each of the paradigms were performed in a minimum of two sepa-
rate experiments; the data were pooled, providing values of 12-18 ani-
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Figure 2. HPLC-EC separation of stand'ards. 
RESULTS 
Most of the parameter.:s measured exhibited a wide range of 
control values between age groups. Tables I and II give the mean 
absolute values ( ± S.E.M.) observed in adult male control animals. 
These figures are similar to those previously reported in the litera-
t 
1,29 
ure • Except for a slightly enhanced striatal DA concentration (p 
<.05), values obtained in the control dams were not signif icantly 
d iff erent from tho se in the adul t males (see Table s III and IV). Due to 
considerable postnatal development of monoaminergic systems in the 
t
7 ,8,24,28 
ra , control values in the offspring and juvenile groups 
changed as a function of their age at the time of sacrifice (see 
Tables III and IV). Most of the dopaminergic parameters reached adul t 
levels by 3 weeks of age, i.e., striatal TH, DOPAC, and HVA and hypo-
thal ami c DA. Striatal DA, however, did increase slightly between 3 
and 7 weeks postnatally, indicating a lag period between maturation of 
the rate-limiting synthetic enzyme and its product. Most of the 
serotonergic parameters increased towards adult values during this 
time period (i.e., striatal and cortical TPH; striatal, cortical, and 
hypothalamic s-HT). In contrast, s-HIAA did not change wi th time in 
any of the areas studied. All parameters reached adult levels by 7 
weeks of age, which is consistent with data reported else-
h 24,28,31 were • Because of these normal fluctua tions in the absolute 
values of the parameters in control tissues, experimental data 
Table I. Levels of 5-HT, DA, and metabolites (~g/mg tissue) in adult male control rats. t 
5-HT 5-HIAA 
Neostriatum 0.537 + .010 0.522 + .030 
Cortex 0.323 + .019 0.178 + .005 
----
Hyp~c:t~~.J-amus 0.712 + .015 0.698 + .033 
tValues are expressed as means + S.E.M.; (N ~ 12) 
tt Not detected 
DA 00 PAC HVA 
8.07 + 0.25 1.10 + 0.07 0.781 + .063 
tt tt tt 





TPH and TH activities (~wles substrate oxidized/g tissue/hour) in adult 
male control rats.t 
TPH TIl 
32.5 + 1.3 3173 + 270 
29.3 + 1.4 tt 




Table III. Levels of S-HT, DA, and metabolites (~g/mg tissue) of 
control rats. t 
5-lIT 5-HIAA DA OOPAC HVA 
_._-----
Dams 
!!~~trlatum O. 620 :t .0 3Q 0.545 :t .037 10.2:t 0 •4 1.1O:t. 07 0.856 + .040 
Cortex 0.242 + .011 0.201.+' .012 
!I y~o.~l~~ ~a.m~ 0.822 :t .041 0.632 + .073 0.488 :t.051 
Juvenile males 
--16h----
Neostriatum 0.416 + .013 0.723 + .064 5.72 :t .20 1.00 + .046 0.761 + .030 
Cortex 0.183 + .010 0.200 :t .011 
Hypothalamus 0.720 + .030 0.750 + .022 0.601 :t .021 
3 wk 
Neostriatum 0.606 + .039 0.663 :t .060 8.70 :t .60 1.14 :t .09 0.747 ± .087 
Cortex 0.222 + .005 0.171 + .011 
Hypothalamus 0.830 :t .037 0.618 + .028 0.625:t .040 
Malt:.~f_~ring 
3 wk 
Neostriatum 0.421 + .024 O. 781 + .033 6.10 + .15 0.950 :t .048 0.950 :t .060 
Cortex 0.112 + .012 0.177 :t .017 
Hypothalamus O. 616 :t .0 72 0.696 + .036 0.629 :t .036 
7 wk 
Neostriatum 0.550 + .020 0.760 :t .052 8.98 + .31 0.916 + .080 0.850:t .081 
Cortex 0.201 + .010 0.175 :t .014 
Hypothalamus 0.840 :t .024 0.640 + .020 0.621 + .031 
t Values are expressed as means :t S.E.M.; N = 12 - 18 
- Not detected 
t--' 
t--' 
Table IV. TPH and TH activities (nMole oxidized/g tissue/hour) 
of control rats.+ 
Dams 

















28.3 + 1.2 
28.2 + 1. 5 
22.8 + 1. 9 
19.5+1.4 
34.6 + 1. 8 
26. 7 + 1. 4 
21.2!1.4 
19.2 + 1.0 
30.6 + 1. 8 
24.3 ! 0.3 
tVa1ues are expressed as means! S.E.M.; ~ = 12 - 18 
ttNot determined 
TH 




2820 + 187 
tt 
3041 :t 107 
tt 




throughout this discussion are expressed as percents of their corre-
sponding controls. 
The lowest dose of AMPH (0.5 mg/kg) caused no significant 
neurochemical changes at any time point tested (data not shown). The 
effects of 5.0 mg/kg AMPH in the neostriatum are shown in Tables V 
and VL The dams were the only group to show uniform depressions in 
all monoamine and metabolite levels. At 3 weeks, the decreases were 
to approximately 80% of the control concentrations of 5-HT, 5-HIAA, 
DA, DO PAC , and HVA. The male offspring sacrificed at the same time 
showed only a slight depletion of DA (to 86%). Whereas striatal TPH 
and TH activities were normal in the dams, the enzymes were signifi-
cantly depressed (to 73 and 80%, respectively) in their offspring. 
Although adult and juvenile males exhibited no changes 16 hours post 
dosing, TPH activity in the adults was increased to 134% of control at 
3 weeks and recovered by 7 weeks. 
There were few changes observed in the cerebral cortex of any 
of the groups (see Table VII). Adult males showed a significant de-
pression of 5-HIAA (to 75% of control) at 16 hours which had recovered 
by 3 weeks. In addi tion, the only changes seen in this study at 7 
weeks post-dosing (data not shown) were in the cortical 5-HT (80 ± 4%) 
and 5-HIAA (86 ± 3%) levels in juvenile-treated males (data not 
shown) • 
The hypothalamus was also relatively insensitive to the drug, 
with juvenile males showing more resistance than the adult-treated 
groups. At 16 hours post dosing, adult 5-HT, 5-HIAA, and DA were de-
pressed to 79%, 68%, and 82% of controls, respectivly, while juvenile-
Table V. 5-HT, DA, and metabolite levels in neostriata of treatment groups at 
16 hand 3 wk post~osing (5.0 mg/kg AMPH, twice daily for two weeks).t 
5-HT 5-HlAA DA 00 PAC HVA 
16 h 
Juvenile males 91 + 7 98 + 5 96 + 4 95 + 4 90 + 4 
- -
Adult males 92 + 4 97 + '7 92 + 4 101 + 5 96 + 6 
- - -
3 wk 
Juvenile males 101 + 6 98 + 6 92 + 4 92 + 5 95 + 5 
- - -
Adult males 95 + 3 96 + 4 103 + 5 105 + 4 95 + 7 
- - -
* * * * * Dams 83 + 3 83 + 4 81 + 2 80 + 5 79 + 5 
- - -
* Male offspring 96 + 8 86 + 11 86 + 3 95 + 5 94 + 6 
-
tValues are expressed as mean percent of corresponding controls ± SEM; N =12-18 per group. 
* Significantly different from control, p < 0.05 t-' 
~ 
Table VI. TPH and TH activities in neostriata of treatment groups at 16 hand 
3 wk post-dosing (5.0 mg/kg AMPH, twice daily for two weeks).t 
TPH TH 
16 h 
Juvenile males 96 + 6 116 + 6 
- -
Adult males 106 + 7 109 + 7 
3 wk 
Juvenile males 101 + 6 106 + 5 
* Adult males 134 + 8 106 + 5 
-
Dams 106 + 4 95 + 6 
* * Male offspring 73 + 6 80 + 3 
t Values are expressed as mean percent of corresponding controls ± SEMj N == 12-18 per group. 
* Significantly different from control, p < 0.05 
I-' 
In 
Table VII. 5-HT and 5-HlAA levels and TPH activity in cerebral 
cortex of treatment groups at 16 hand 3 wk post-
dosing (5 mg/kg AMPH, twice daily for two weeks).t 
5-HT 5-HlAA TPH 
16 h 
Juvenile males 90 ~ 5 92 + 6 98 ~ 3 
* Adult males 90 ~ 5 75 ~ 7 77 + 10 
~ 
Juvenile males 92 + 6 89 + 7 99 + 4 
Adult males III + 6 110 + 6 105 + 5 
Dams 88 + 7 94 + 8 84 ~ 5 
Male offspring 98 :t 8 104 + 8 98 :t 6 
tValues are expressed as mean percent of corresponding controls ± SEM; 
N = 12-18 per group 
* Significantly different from control, p < 0.05 
16 
17 
treated rats did not differ from their controls (see Table VIII). 
To determine whe ther a larger do se of AMPH in this do sing 
regimen would induce more severe or longer-lasting neurochemical 
changes, one additional dosing experiment was performed (N = 6-8 per . 
group). Juvenile and adult males were dosed with 10 mg/kg AMPH twice 
daily for 2 weeks (as described above). Pregnant females could not be 
used due to an exceptionally high mortality rate at this dose level. 
From these preliminary data (see Tables IX and X), a significant dose-
effect component of AMPH-induced toxicity in this dosing paradigm was 
apparent. Quantitatively, more significant changes were seen in both 
groups at this higher dose. In the striata of juvenile males 5-HT and 
5-HIAA were greatly depleted, being 64% and 68% of respective controls 
at 16 hours. These had completely recovered by 3 weeks, whereas 
smaller decreases in DA and RiA (each to 84% of controls) at 16 hours 
had not recovered by 3 weeks. Striatal TPH was elevated in the adult 
males at both time points and TH was significantly increased at 3 
weeks, without accompanying changes in monoamine levels. Juvenile 
males exhibited striatal TH activity of 137% of control at 16 hours, 
with recovery to control by 3 weeks. 
Cortical 5-HIAA was decreased in both groups at 16 hours; this 
was the only change observed in this brain region at the high (10 
mg/kg) dose. Hypothalamic levels of 5-HT and DA that were depleted at 
16 hour s in adul ts and j uvenil es, respectively, had returned to con-
trol by 3 weeks. 
Table VIII. 5-HT, 5-HIAA, and DA levels in hypothalamus of treatment groups 
at 16 hand 3 wk post-dosing (5 mg/kg AMPH, twice daily for two 
weeks). 
5-Hf 5-HlAA DA 
16 h 
Juvenile males 94 + 2 96 + 3 90 + 3 
* * * Adult males 79 + 2 68 :t 3 82 + 5 
3 wk 
Juven He ma les 96 + 3 95 :t 3 96 + 3 
Adult males 119 + 8 128 + 11 92 + 10 
Dams 88 + 4 96 + 3 96 + 5 
Male offspring 106 + 7 101 + 4 95 + 5 
t Values are expressed as mean percent of corresponding controls ! SEMj 
N 12-18 per group. 
* Significantly different from control, p < 0.05 
....... 
00 
Table IX. 5-HT, 5-HIAA, and DA levels and TPH activities in cerebral cortex and hypothalamus 
of juvenile- and adult-treated males at 16 hand 3 wk post-dosing (10 mglkg AMPH, 




Juvenile males 92 + 4 
Adult males 89 + 9 
3 wk 
Juvenile males 98 + 5 
Adult males 105 + 6 
Hypothalamus 
16 h 
Juvenile males 90 + 3 
Adult males 79 ± 2 
3 wk 
Juvenile males 98 + 1 
Adult males 96 + 6 
* 
5-HIAA 
*-75 + 3 
* 81 + 5 
114 + 4 
115 + 11 
'* 81 + 3 
'* 71 + 4 
98 + 2 
104 + 4 
DA 
'* 87 + 4 
99 + 9 
100 ± 7 
105 + 4 
t Values are expressed as mean percent of corresponding controls ± 
Significantly different from control, p < 0.05 
- Not detected 
tt Not determined 
TPH 
98 + 4 
74 + 12 






SEMi N - 6 -8 per group 
...... 
\0 
Table X. 5-HT, DA, and metabolite levels and TPH and TH activities in neostriata 
of juvenile- and adult-treated males at 16 hand 3 wk post-dosing (10 mg/kg 
AMPH, twice daily for two weeks),t 




* * * * 
.bvenile males 64 + 10 68 + 8 84 + 3 88 + 7 841"5 104 + 3 137 + 8 
* * Adult males 87 + 3 98 + 8 89 + 5 106 + 6 125 + 9 129 + 9 110 + 7 
3 wk 
* * Juvenile males 94 + 2 96 + 4 84 + 3 90 + 3 85 :! 4 104 + 6 100 + 4 
* * Adult males 128 + 25 95 + 16 102 + 8 123 :! 13 126 + 13 124 + 9 119 + 6 
--------
tValues are expressed as mean percent of corresponding controls :!: SEM; N ... 6 - 8 per &roup 
.. 




The control data document the developmental changes that occur 
in the dopaminergic and serotonergic systems in three discrete brain 
regions of the rat (Tables I, II, III, and IV). As both systems were 
monitored simultaneously in the same animals, several generalizations 
can be made. First, the neuronal systems studied here are not mature 
at birth in the rat, which is widely accepted. Secondly, different 
areas of the brain do not mature at the same rate. For example, 
hypothalamic DA was at adult levels by 3 weeks postnatally, whereas 
striatal DA reached matute levels only after 7 weeks. Finally, the 
different neurotransmitter systems do not mature at the same time; in 
the regions examined the dopaminergic system, generally, matured 
earlier than the serotonergic system. This has obvious significance 
for the development of any physiological functions, such as behavior, 
that depend upon the relative balance between such neurotransmitter 
systems for their expression. 
The most striking observation from the experimental data is 
tha t AMPH, in this do sing regimen, caused only minimal, rever si ble 
neurochemical changes. This is in sharp contrast to the severe, long-
lasting depressions of both the serotonergic and dopaminergic systems 
1 9 14 that have been observed after high-dose subacute drug exposure " , 
33,39 Short-term exposure to low doses of METH does not cause 
10 14 . toxicity in these neurotransmitter systems ' ; a s~ngle dose of up 
22 
to 1 mg/kg AMPH actually increases the synthesis of DA in the 
striatum19 ,2l. The low doses used in this study (0.5 or 5 mg/kg AMPH) 
may be below the threshold required to produce neuronal depletion. 
This is an important finding, clinically, as AMPS is prescribed within 
this approximate dose range for chronic use in humans4l • 
Administration of AMPH (5 mg/kg) to pregnant rats produced 
some intriguing resul ts (Tabl es V and VI). At 3 weeks of age, male 
offspring of these dams exhibited normal striatal monoamine levels 
while the corresponding synthetic enzymes were significantly de-
pressed. Results from similar studies have been variable5 ,13,26,32, 
possibly due to wide discrepancies in doses and dosing regimens 
employed. In addition, many of the biochemical data reported to date 
for in- utero AMPH exposure have been data obtained from whole brain 
5 ·26 homogena tes' which could easily mask the localized neurochemical 
changes that are detected in the present study. 
Another important facet of these data is that they allow 
direct comparisons of effects on the offspring wi th effects on the 
treated dams. At a time that only enzymatic changes were present in 
the offspring (3 weeks), enzyme activities were normal in the dams but 
5-HT, 5-HIAA, DA, DOPAC, and HVA levels were depressed. Since the 
data reflect only two time points after dosing, a complete explanation 
of the maternal-fetal interaction in response to chronic AMPS chal-
lenge during gestation is not possible. Enzyme activities in the dams 
may have been decreased during dosing and/or shortly thereafter but 
recovered by 3 weeks after dosing. A lag period in restoration of 
neurotransmitter levels after TIl or TPH inhibition and recovery has 
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b d . 1 d . . 2 d . 30 een reporte 1n centra opam1nerg1c an serotonerg1c systems, 
respectively. This could explain the depression in monoamines and 
metabolites observed here at 3 weeks. The offspring were exposed to 
-AMPH in utero during the critical periods for development of the 
cerebral cortex (days 13-17 of gestation) and striatum (days 15-18 of 
. )3 gestat10n • Clearly, however, the neurochemical changes seen in 
these areas postnatally were minimal and temporary. The fetus may 
have a decreased sensitivity to this drug because of the immaturity 
of, or an increased plasticity in, the neuronal systems on which AMPH 
is known to act. Offspring and dams fully recovered from the drug 
insult, as all parameters were normal in both groups by 7 weeks post 
dosing. With the low doses of AMPH used in this chronic dosing 
regimen, the drug does not exhibit potent biochemical teratogenicity. 
A comparison of the juvenile- and adult-treated males in the 
present study (5 mg/kg) shows that the neurotoxic effects in the 
hypothalamus appeared to be dependent upon the age of the animal at 
the time of exposure. At 16 hours post dosing, DA, 5-HT, and 5-HlAA 
were signif icant ly depressed only in the adul ts. Preliminary data 
using 10 mg/kg per dose suggest that immature animals are not totally 
protected from the toxicity. Changes similar to those seen in the 
adults were produced in the juveniles at this higher dose. The depen-
dence upon age for low-dose production of toxicity in the hypothalamus 
was not apparent in the other brain regions studied. Time- and 
dose-response studies are required to evaluate the importance of this 
finding. The present data underline, however, the importance of dose-
response in the production of AMPH-induced neurotoxicity. Under the 
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conditions of this study, the severity of AMPH-induced toxicity did 
not increase dramatically in magnitude nor duration as a function of 
the age of the animal at the time of exposure. 
Sex-related differences in behavioral sensitivity to AMPH have 
been studied in detail. Female rats show greater increases in activi-
ty levels and stereotypy than do males given equivalent doses4 ,35 • 
AMPH is metabolized more rapidly in males, but when the administered 
dose is adjusted to give equivalent concentrations of AMPH in the 
brains of both sexes, females still show the greater behavioral 
response4 • The present study extends these findings to a biochemical 
level. The females in this study {Table V} were more sensitive to 
chronic AMPH exposure than either of the treated male groups {juvenile 
or adult}. The striatal depressions observed in the dams at 3 weeks 
post dosing (5 mg/kg) were, however, reversed by 7 weeks. 
Intra-regional differences in sensitivity to AMPH were appar-
ent, the hypothalamus showing a relative resistance, as reported else-
wherel ,33. One possible explanation for the small magnitude and short 
duration of neurochemical changes in this area involves the 
availability of hydroxylase cofactor. Levine et 81. 22 showed a strong 
correlation between total hydroxylase activity {m + TPH} and the 
concentration of the natural cofactor, tetrahydrobiopterin (BH4 ) , in 
ten discrete regions of the rat brain. Most of the areas studied, 
including the striatum and cerebral cortex, exhibit hydroxylase ac-
tiv ity linearly proportional to the amount of cofactor present. In 
the hypothalamus, however, there is a great excess of pterin for the 
amount of hydroxylase activity present. Our laboratory is currently 
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investigating the possibility that the neurotoxicity of the amphet-
amines involves depletion or inactiviation of this cofactor. If this 
theory is correct, areas such as the hypothalamus, containing a rela-
tive abundance of BH4 would not be expected to show extensive depres-
sions in hydroxylase activity (nor the corresponding depletions in 
neurotran8mitters) in response to amphetamine challenge. 
The two brain areas selected for their reported sensi tivi ty 
to AMPH, the cortex and striatum, also showed very few significant 
changes. The changes that did occur were minor and short-lived. This 
cannot be attributed solely' to a dose-response effect, as the highest 
dose used (10 mg/kg) has been shown to cause severe depletions when 
administered subacutely38. The present data support the idea that 
AMPH neurotoxicity can be greatly affected not only by dose level but 
also by duration of dosing. 
The importance of the relative contributions of dose and dura-
tion of exposure on the neurotoxicity of amphetamines was illustrated 
in an early report by Koda and Gibb17 • At least 10 or 15 mg/kg per 
dose of METH was necessary to decrease striatal TH when the drug was 
given every 6 hours for 8 doses (sacrifice 6 hours after the last 
dose). A similar paradigm has been used by many researchers to induce 
h . 1 d 1 . 1,10,14,33 H . h . d severe neuroc emlca ep etlons • owever, Wlt contlnue 
dosing of METH (every 6 hours for 66 hours), TH activity in the 
striatum returned to normal levels by 60 hours, and appeared augmented 
by 72 hours, after the first dose l7 • These results were confirmed and 
18 
extended by Kogan et al. Data were also obtained from the substan-
tia nigra, a site of dopaminergic cell bodies which project axons to 
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the striatum. With continued dosing of METH, TH activity was depressed 
1 · d d f . h· h· h . 18 ear ler, an recovere aster, ln t e nlgra t an ln t e strlatum • 
Additional research is needed to elucidate the mechanism of 
dopaminergic system recovery with continued amphetamine exposure. 
This study lends preliminary support to the possibility that a similar 
recovery phenomenon occurs in the serotonergic system. Adult-treated 
males showed an apparent rebound increase in striatal TPH activity 3 
weeks after the moderate dose (5 mg/kg, Table VI) and at 16 hours and 
3 weeks after the highest dose (10 mg/kg, Table X). 
Some of the effects observed in this study could have been 
caused by drug-induced changes in receptor populations. Several dif-
ferences in receptor-mediated events occur as functions of dose level 
and duration of dosing of AMPH. High-dose subacute exposure decreases 
h b f d . . . d . b· d· . 36 d t e num er 0 opamlnerglc agonlst an antagonlst In lng sltes an 
the density of 3(H)-DA uptake sites39 • Conversely, lower dose, 
chronic AMPH exposure increases striatal DA binding34 • Certainly, the 
neuronal system can respond differently at the molecular level to 
distinct types of drug challenge. Receptor changes must be included 
as offering plausible, if partial, explanations for the neurochemical 
effects reported here. 
A single dose of 9.2-36.8 mglkg AMPH administered with 
iprindole, which greatly slows elimination of the former drug, causes 
. d 1· . h . 1 d .. 11,12,38 perslstent ep etlons ln t e strlata opamlnerglc system • 
This has been used as a model for the neurotoxic effects of continuous 
central AMPH exposure. Implantation of AMPH-releasing pellets for 7 
days depletes striatal TH activity for as long as 110 days. If the 
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same absolute dose is administered in divided daily injections over 7 
days, no change of enzyme activity occurs9. These reports and the 
present study lend support to the concept that neuronal damage caused 
by AMPH is at least partially dependent upon an extended persistence 
of the drug in the brain. The greatest reported neurotoxicity caused 
by the amphetamines occurs after frequent administration or in the 
presence of a metabolic inhibitor that increases the brain .half-life 
of the parent compound. Toxicity is greatly attenuated, however, in 
the chronic dosing regimen used here. 
The central serotonergic and dopaminergic systems examined in 
this study appear to compensate for chronic, intermittent AMPH chal-
lenge, thereby reversing many of the neurotoxic effects that occur 
after short-term exposure. 
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